Biochemical and Biophysical Research Communications 1996-08-05

Regulation of fatty acid biosynthesis by intermediates of the cholesterol biosynthetic pathway.

E C Ku

Index: Biochem. Biophys. Res. Commun. 225(1) , 173-9, (1996)

Full Text: HTML

Abstract

The biosynthesis of cholesterol and fatty acid (FA) proceeds by independent pathways. Information is lacking on potential interaction that could provide feedback regulation between these pathways. In an attempt to search for a new approach to produce a dual effect on regulation of these two processes, we have identified mevalonate-5-diphosphate (MevPP) decarboxylase, an enzyme of the cholesterol biosynthesis pathway, the inhibition of which leads not only to the suppression of cholesterol but also FA biosynthesis. Mechanistic studies with Hep G2 cells using specific inhibitors for MevPP decarboxylase and related enzymes reveal that the inhibitory effect on FA biosynthesis is mainly due to the accumulation of MevPP, resulting from MevPP decarboxylase inhibition. The present study proposes a new mechanism through which interpathway regulation could take place between the cholesterol and FA cascades.


Related Compounds

Related Articles:

[Pharmacological control of biosynthesis pathway of mevalonate: effect on the proliferation of arterial smooth muscle cells].

1997-01-01

[C. R. Seances. Soc. Biol. Fil. 191(2) , 169-94, (1997)]

Effect of lovastatin and fluoromevalonate on phosphatidylinositol 3-kinase activity stimulated with PDGF.

1995-12-01

[Clin. Exp. Pharmacol. Physiol. Suppl. 22(1) , S318-20, (1995)]

Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.

2011-04-01

[Biochim. Biophys. Acta 1811(4) , 227-33, (2011)]

Proliferative effect of mevalonate metabolites other than isoprenoids on cultured vascular smooth muscle cells.

1993-01-01

[Clin. Exp. Pharmacol. Physiol. 20(7-8) , 509-14, (1993)]

Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism.

1995-04-15

[Cancer Res. 55(8) , 1732-40, (1995)]

More Articles...